IM Cannabis Stock (NASDAQ:IMCC)


OwnershipChart

Previous Close

$0.12

52W Range

$0.10 - $3.13

50D Avg

$0.18

200D Avg

$0.79

Market Cap

$384.76K

Avg Vol (3M)

$5.36M

Beta

2.04

Div Yield

-

IMCC Company Profile


IM Cannabis Corp. specializes in the cultivation, production, and provision of medicinal cannabis goods throughout international markets such as Israel, Germany, and Canada. The company offers a range of cannabis products, including flowers and specifically formulated cannabis extracts, marketed under its IMC brand. Furthermore, it supplies dried flower, pre-rolled products, and compressed hashish via its WAGNERS and Highland Grow labels. IM Cannabis Corp. serves a broad customer base, addressing the needs of both medical patients and adult recreational consumers. Its corporate headquarters are located in Tel Aviv-Yafo, Israel.

Show More

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

IL

Employees

44

IPO Date

May 20, 2020

Website

IMCC Performance


Latest Earnings Call Transcripts


Q1 25May 15, 25 | 9:00 AM
Q4 24Mar 31, 25 | 9:00 AM
Q3 24Nov 14, 24 | 9:00 AM

Peer Comparison


TickerCompany
AKANAkanda Corp.
SHPHShuttle Pharmaceuticals Holdings, Inc.
VEROVenus Concept Inc.
GRIGRI Bio, Inc.
JAGXJaguar Health, Inc.
NAOVNanoVibronix, Inc.
FLGCFlora Growth Corp.
NDRAENDRA Life Sciences Inc.
RDHLRedHill Biopharma Ltd.